A number of new arylamides (2a-o), sulphonamides (3a-p) and 5-oxo imidazolines (4a-o) have been synthesised by the condensation of acid hydrazide of o-benzoylene-2,1-benzimidazole 1 with different aromatic acid chlorides, aryl carboxy sulphonylchlorides and azlactones in dry pyridine. All the productswere evaluated invitro for their antimicrobial activity against several microbes and antitubercular activity against Mycobacterium tuberculosis H37Rv.
INTRODUCTION
Although a large number of benzimidazole analogs have been synthesised, there still exists much scope for the synthesis of benzimidazole derivatives possessing different pharmacophores.
(1-5).
Literature survey reveals that various arylamides, sulphonamides and 5-oxo-imidazolines have resulted in many potential drugs. This observation prompted us to synthesise some new aryl amides (6, 7) , sulphonamides (8, 9 ) and 5-oxo-imidazolines (10, 11) derivatives bearing benzimidazole moiety, with a view to studying their pharmacological profile. 
RESULTS AND DISCUSSION
Arylamides (2a-o) and 5-oxo-imidazolines (4a-o) were tested invitro for antimicrobial activity against Gram-positive bacteria Bacillus megaterium, and Bacillus subtilis, Gram-negative bacteria Escherichia coli and Pseudomonas fluorescens and fungi Aspergillus awamori.
Activity of the compounds was compared with known antibiotics at the same concentration level. All the new synthesised compounds reported in Table-1 were screened in vitro for their antitubercular activity against Mycobacterium Tuberculosis H37Rv. The activity exhibited by reference standard drug Rifampin (which showed 97% inhibition) was compared.
The antitubercular activity data showed that some of the compounds exhibited significant activity against H37Rv strain. It has been observed from the Table-2 , that compounds 2b, 2f, 4d, 3d, 3i, 4f showed good activity (>50% inhibition). The compounds 2k, 3a, 4o have been selected for their pharmaceutical screening by E. MERCK Ltd. USA.
IΝ VITRO EVALUATION OF BIOLOGICAL STUDIES
The antitubercular evaluation of the compounds was carried out at "Tuberculosis Antimicrobial Acquisition And Coordinating Facility" (TAACF) USA. Primary screening of the compounds for antitubercular activity have been conducted at 12.5 ug/ml against Mycobacterium tuberculosis H37Rv, in BACTEC 12B medium using BACTEC 460 radiometric system. Antitubercular activity data were compared with standard drug Rifampin at 0.031 μg/ml concentration which showed 97% inhibition.
Compounds (2a-o) and (4a-o) were screened in vitro for antibacterial and antifungal activities at 50μg / ml concentrations. The test organisms chosen were Bacillus megaterium, Bacillus Subtilis, Escherichia coli, Pseudomonas flourescens and fungi Aspergillus awamori.
Cup-plate agar diffusion method (14) was used to measure the activity. Known antibiotics like Ampicillin, Chloramphenicol, Norfloxacin and Greseofulvin were used for comparison purpose.
EXPERIMENTAL
All the melting points are taken in open capillary in a liquid paraffin bath and are uncorrected.
Purity of all compounds were checked by TLC. Infra red spectra (KBr) were recorded on Shimadzu-435-IR Spectrophotometer and 1 H-PMR Spectra on Brucker-300F MHz using TMS as an internal standard.
Preparation of Benzimidazol-2-yl-o-benzoyl hydrazide 1
A mixture of o-benzoylene-2, 1-benzimidazole (1.68g, 0.01 mol) and hydrazine hydrate (0.5 ml, 0.01 mol) was refluxed for 3 hrs in oil bath at 120°C. 
Preparation of Benzoyl-(benzimidazol-2'-yl-o-benzoyl) hydrazines (2a-o).
A mixture of aromatic acid (1 gm) and thionyl chloride ( 5ml) was refluxed for 6 hrs. in water Similarly other members of 2 were synthesised. The physical constants are recorded in Table - 1.
Preparation of Aryl sulphonyl-(benzimidazol-2'-yl-o-benzoyl) hydrazines (3a-p).
Benzimidazol-2-yl-o-benzoyl hydrazide 1 (0.01 mol) and aryl carboxy sulphonyl chloride (0.01 mol) was refluxed in dry pyridine (10 ml) for 4-5 hours. The content was poured on to crushed ice. Similarly other members of 3 were synthesised. The physical constants are recorded in Table - 1.
Preparation of 4-Arylidene-(benzimidazol-2'-yl-o-benzamido)-2-phenyl-5-oxo-imidazolines (4a-o).
Benzimidazol 
563
Vol. 4, No. 6, 1998 Synthesis of some arylamides, sulphonamides and 5-oxo-imidazolines as novel bioactive compounds derived from benzimdazole Vol. 4, No. 6, 1998 Synthesis of some arylamides, sulphonamides and 5-oxo-imidazolines as novel bioactive compounds derived from benzimdazole
